Vincristine

Overview

4.3 out of 5 (7 Reviews)

Credits

1.50

Post Assessment Questions

12

Start Date

1 Jan 2023

Last Review Date

1 Jan 2023

Expiration Date

31 Dec 2025

Estimated Time To Finish

90 Minutes


 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Vincristine belongs to a group of drugs known as the vinca alkaloids. Vinca alkaloids are organic compounds made up of carbon, hydrogen, nitrogen, and oxygen derived from the periwinkle plant. These drugs block cell growth by stopping mitosis by interfering with microtubule polymerization. The FDA-approved indications of vincristine are acute lymphocytic leukemia, lymphoid blast crisis of chronic myeloid leukemia, and Hodgkin and Non-Hodgkin lymphoma. Vincristine also has several off-label uses that include central nervous system (CNS) tumors, Ewing sarcoma, gestational trophoblastic tumors, multiple myeloma, ovarian cancer, primary CNS lymphoma, small cell lung cancer, and advanced thymoma in adult patients. This activity outlines the indications, mechanism of action, methods of administration, important adverse effects, contraindications, toxicity, and monitoring, of vincristine so providers can direct patient therapy in cancer treatment where it is indicated as part of the interprofessional team.


Target Audience

This activity has been designed to meet the educational needs of individuals in nursing.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify the mechanism of action of vinca alkaloids like vincristine.
  • Summarize the indicated cancers for which vincristine is a therapeutic option.
  • Review the adverse event profile for vincristine.
  • Describe the importance of collaboration and coordination among the interprofessional team and how it can enhance patient care with vincristine therapy to improve patient outcomes for patients who have cancers for which it is indicated.

Disclosures

StatPearls requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. None of the planners of this educational activity have any relevant financial relationships to disclose.

COMMERCIAL SUPPORT: This activity has received NO commercial support.

 

Continuing Education Accreditation Information

Credit provided by Continuing Education, Inc, and StatPearls, LLC.

In support of improving patient care, this activity has been jointly planned and implemented by Continuing Education, Inc./University at Sea® and StatPearls, LLC. Continuing Education, Inc, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity is designated for 1.50 ANCC contact hours.

 

Instructions for Credit

  1. Register for the activity and create a StatPearls login.     
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content in the activity.
  4. Choose the best answer to each activity test question. To receive credit, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment.
  6. Obtain a certificate.

For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

Disclaimer

Faculty may discuss investigational products or off-label uses of products regulated by the US Food and Drug Administration. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Cancellation Policy: Cancellations must be received in writing and a money-back guarantee is provided if not completely satisfied.

  • StatPearlsand and Continuing Education, Inc, reserve the right to cancel any course due to unforeseen circumstances. StatPearls and Continuing Education, Inc, will not be responsible for other expenses incurred by the participant in the unlikely event that the program is canceled.

Medium or Media Used:

  • Computer Requirements: Internet Access
  • E-mail Address

Equal Opportunity

  • StatPearls and Continuing Education are Equal Opportunity/Affirmative Action/Equal Access Institutions. 

 

 
 

Reviews

Christopher C. on 8/12/2021

Elizabeth E. on 6/22/2022

most of the questions surrounded the point of vincristine being a cell- cycle specific medication that works in the m phase which I am not sure is clinically relevant.

Morgan P. on 6/28/2022

Shannon j. on 7/9/2022

Theodore B. on 11/19/2022

on 12/28/2022

Jamie K. on 4/17/2023

Unlimited Nurse CE

Stay up to date on the latest medical knowledge with 6680 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7946 hours of CE.

1 Year Unlimited Nurse CE

Access to all the Unlimited Nurse CE activities in all specialties.

$39.99 per 1 year per user